Breakthrough Peptide Technology
Hybridtides® are a new class of drug candidates that deliver unique product profiles.
Longevity Biotech has multiple preclinical programs in development all based on the Hybridtide® core technology.Pipeline
Oral Peptide Delivery
Hybridtides® demonstrate robust durability in a variety of biological matrices. Absorption parameters are optimized via our proprietary databases.
The unique composition of Hybridtides® (natural and non-natural amino acids) enables 'fine-tuning' of intracellular signal cascades. In other words, Hybridtides® demonstrate signal bias.
Peer Reviewed Papers
600 South 43rd Street
Philadelphia, PA 19104